Teladoc Health, Inc.
New York Stock ExchangeTotal Valuation
Teladoc Health, Inc. carries a market capitalization of 1.14B, placing it among publicly traded companies globally. Its enterprise value stands at 1.80B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.14B |
| Enterprise Value | 1.80B |
Share Statistics
Teladoc Health, Inc. currently has 181.65M shares outstanding.
| Shares Outstanding | 181.65M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.61, and the price-to-book ratio stands at 1.18.
| PE Ratio | N/A |
| PS Ratio | 0.61 |
| PB Ratio | 1.18 |
| P/TBV Ratio | -10.36 |
| P/FCF Ratio | 5.80 |
| P/OCF Ratio | 5.80 |
Enterprise Valuation
On an enterprise value basis, Teladoc Health, Inc. trades at an EV/EBITDA multiple of 7.76 and an EV/FCF ratio of 6.42.
| EV / Sales | 0.72 |
| EV / EBITDA | 7.76 |
| EV / EBIT | N/A |
| EV / FCF | 6.42 |
Financial Position
Teladoc Health, Inc. maintains a current ratio of 0.83, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 79.09, indicating elevated leverage, while an interest coverage ratio of 11.64 demonstrates strong ability to service its debt obligations.
| Current Ratio | 0.83 |
| Quick Ratio | 0.73 |
| Debt / Equity | 79.09 |
| Debt / EBITDA | 4.46 |
| Interest Coverage | 11.64 |
Financial Efficiency
| Return on Equity (ROE) | -12.99 |
| Return on Assets (ROA) | -6.28 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 23.07 |
Taxes
| Income Tax | -5.20M |
| Effective Tax Rate | N/A |
Stock Price Statistics
Teladoc Health, Inc.'s stock has declined approximately -20.75472% over the past 52 weeks. The 50-day moving average sits at 7.29, while the 200-day moving average is 6.65.
| Beta (5Y) | N/A |
| 52-Week Price Change | -20.75472% |
| 50-Day Moving Average | 7.29 |
| 200-Day Moving Average | 6.65 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Teladoc Health, Inc. generated 2.49B in revenue and converted that into -177.39M in net income, yielding earnings per share of -0.99. EBITDA reached 232.31M, while operating income came in at -145.65M.
| Revenue | 2.49B |
| Gross Profit | 1.72B |
| Operating Income | -145.65M |
| Pretax Income | -182.59M |
| Net Income | -177.39M |
| EBITDA | 232.31M |
| EBIT | -145.65M |
| Earnings Per Share (EPS) | -0.99 |
Balance Sheet
Teladoc Health, Inc. holds 774.35M in cash and equivalents against 1.04B in total debt, resulting in a net debt position of 222.35M. Total book value stands at 1.31B, with working capital of -233.37M providing operational flexibility.
| Cash & Cash Equivalents | 774.35M |
| Total Debt | 1.04B |
| Net Debt | 222.35M |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 7.21 |
| Working Capital | -233.37M |
Cash Flow
Teladoc Health, Inc. produced 261.18M in operating cash flow over the past twelve months.
| Operating Cash Flow | 261.18M |
| Capital Expenditures | N/A |
| Free Cash Flow | 261.18M |
| FCF Per Share | 1.46 |
Margins
Teladoc Health, Inc. operates with a gross margin of 68.97, reflecting its pricing power and cost economics. The operating margin of -5.85 and net profit margin of -7.13 provide insight into operational efficiency.
| Gross Margin | 68.97 |
| Operating Margin | -5.85 |
| Pretax Margin | -7.33 |
| Profit Margin | -7.13 |
| EBITDA Margin | 9.33 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.26 |
| FCF Yield | 17.23 |
Scores
Teladoc Health, Inc. posts an Altman Z-Score of -15.84, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -15.84 |